{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:39:24Z","timestamp":1765546764005,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jpba.2021.114147","type":"journal-article","created":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T14:14:18Z","timestamp":1621347258000},"page":"114147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Liquid chromatography-mass spectrometry based metabolic characterization of pleural effusion in patients with acquired EGFR-TKI resistance"],"prefix":"10.1016","volume":"202","author":[{"given":"Na","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weimin","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ding","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengbo","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongjian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2021.114147_bib0005","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1158\/1078-0432.CCR-19-3972","article-title":"Integrative omics analysis reveals soluble Cadherin-3 as a survival predictor and an early monitoring marker of EGFR tyrosine kinase inhibitor therapy in lung cancer","volume":"26","author":"Hsiao","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jpba.2021.114147_bib0010","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.lungcan.2016.10.010","article-title":"Lung cancer mutation profile of EGFR, ALK, and KRAS: meta-analysis and comparison of never and ever smokers","volume":"102","author":"Chapman","year":"2016","journal-title":"Lung Cancer."},{"key":"10.1016\/j.jpba.2021.114147_bib0015","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-019-1244-2","article-title":"Protein tyrosine kinase 2: a novel therapeutic target to overcome acquired EGFR-TKI resistance in non-small cell lung cancer","volume":"20","author":"Tong","year":"2019","journal-title":"Respir. Res."},{"key":"10.1016\/j.jpba.2021.114147_bib0020","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/s41388-018-0482-y","article-title":"Targeting the EMT transcription factor TWIST1 overcomes resistance to EGFR inhibitors in EGFR-mutant non-small-cell lung cancer","volume":"38","author":"Yochum","year":"2019","journal-title":"Oncogene."},{"key":"10.1016\/j.jpba.2021.114147_bib0025","doi-asserted-by":"crossref","first-page":"i10","DOI":"10.1093\/annonc\/mdx703","article-title":"Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors","volume":"29","author":"Westover","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jpba.2021.114147_bib0030","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-019-1601-6","article-title":"AXL degradation in combination with EGFR-TKI can delay and overcome acquired resistance in human non-small cell lung cancer cells","volume":"10","author":"Kim","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jpba.2021.114147_bib0035","doi-asserted-by":"crossref","first-page":"62648","DOI":"10.18632\/oncotarget.16061","article-title":"Addition of bevacizumab for malignant pleural effusion as the manifestation of acquired EGFR-TKI resistance in NSCLC patients","volume":"8","author":"Jiang","year":"2017","journal-title":"Oncotarget."},{"key":"10.1016\/j.jpba.2021.114147_bib0040","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/cncy.21832","article-title":"Metabonomics by proton nuclear magnetic resonance in human pleural effusions: a route to discriminate between benign and malignant pleural effusions and to target small molecules as potential cancer biomarkers","volume":"125","author":"Zennaro","year":"2017","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.jpba.2021.114147_bib0045","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1080\/14737159.2019.1656530","article-title":"The applications of metabolomics in the molecular diagnostics of cancer","volume":"19","author":"Cheung","year":"2019","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.jpba.2021.114147_bib0050","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.talanta.2016.08.007","article-title":"Prediction of biomarkers of therapeutic effects of patients with lung adenocarcinoma treated with gefitinib based on progression-free-survival by metabolomic fingerprinting","volume":"160","author":"Zhuang","year":"2016","journal-title":"Talanta."},{"key":"10.1016\/j.jpba.2021.114147_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2019.113069","article-title":"Metabolic and lipidomic characterization of malignant pleural effusion in human lung cancer","volume":"180","author":"Yang","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2021.114147_bib0060","doi-asserted-by":"crossref","DOI":"10.1038\/srep35110","article-title":"Lipidomic profiling of lung pleural effusion identifies unique metabotype for EGFR mutants in non-small cell lung cancer","volume":"6","author":"Ho","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpba.2021.114147_bib0065","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ccell.2020.04.014","article-title":"SETD5-coordinated chromatin reprogramming regulates adaptive resistance to targeted pancreatic Cancer therapy","volume":"37","author":"Wang","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jpba.2021.114147_bib0070","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.celrep.2019.06.026","article-title":"Branched-chain amino acid metabolic reprogramming orchestrates drug resistance to EGFR tyrosine kinase inhibitors","volume":"28","author":"Wang","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.jpba.2021.114147_bib0075","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jpba.2021.114147_bib0080","doi-asserted-by":"crossref","first-page":"983","DOI":"10.4155\/bio-2018-0090","article-title":"Progress in high-sensitivity hybrid LC-MS\/MS methods for the bioanalysis of protein drugs and performance tests for their validation","volume":"10","author":"Duggan","year":"2018","journal-title":"Bioanalysis."},{"key":"10.1016\/j.jpba.2021.114147_bib0085","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.4155\/bio-2018-0122","article-title":"Twins derivatization-based LC-MS: a promising quantitative tool for metabolomic analysis","volume":"10","author":"Li","year":"2018","journal-title":"Bioanalysis."},{"key":"10.1016\/j.jpba.2021.114147_bib0090","doi-asserted-by":"crossref","first-page":"9571","DOI":"10.1021\/acs.analchem.9b00863","article-title":"Living-cell imaging of mitochondrial membrane potential oscillation and phenylalanine metabolism modulation during periodic electrostimulus","volume":"91","author":"Qi","year":"2019","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2021.114147_bib0095","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1021\/acs.jproteome.6b00076","article-title":"Distinct metabolic signature of human bladder Cancer cells carrying an impaired fanconi Anemia tumor-Suppressor signaling pathway","volume":"15","author":"Panneerselvam","year":"2016","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jpba.2021.114147_bib0100","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.nut.2018.06.002","article-title":"Perioperative serum and urine metabolome analyses in patients with hepatocellular carcinoma undergoing partial hepatectomy","volume":"58","author":"Kajiura","year":"2019","journal-title":"Nutrition."},{"key":"10.1016\/j.jpba.2021.114147_bib0105","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s12276-020-0375-3","article-title":"Amino acids in cancer","volume":"52","author":"Lieu","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jpba.2021.114147_bib0110","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/01635589709514610","article-title":"Tyrosine and phenylalanine restriction induces G0\/G1 cell cycle arrest in murine melanoma in vitro and in vivo","volume":"29","author":"Fu","year":"1997","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.jpba.2021.114147_bib0115","first-page":"877","article-title":"Decreased tissue plasminogen activator and increased plasminogen activator inhibitors and increased activator protein-1 and specific promoter 1 are associated with inhibition of invasion in human A375 melanoma deprived of tyrosine and phenylalanine","volume":"18","author":"Pelayo","year":"2001","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.jpba.2021.114147_bib0120","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.4155\/bio-2018-0041","article-title":"Determination of kynurnine and tryptophan, biomarkers of indoleamine 2,3-dioxygenase by LC-MS\/MS in plasma and tumor","volume":"10","author":"Wang","year":"2018","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2021.114147_bib0125","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00262-014-1549-4","article-title":"Indoleamine 2.,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer","volume":"63","author":"Prendergast","year":"2014","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.jpba.2021.114147_bib0130","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1158\/1055-9965.EPI-13-0770","article-title":"Circulating biomarkers of tryptophan and the kynurenine pathway and lung cancer risk","volume":"23","author":"Chuang","year":"2014","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.jpba.2021.114147_bib0135","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.lungcan.2009.05.001","article-title":"Increased serum kynurenine\/tryptophan ratio correlates with disease progression in lung cancer","volume":"67","author":"Suzuki","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jpba.2021.114147_bib0140","series-title":"Metabolic Markers As Cancer clues Science","first-page":"1265","author":"Mayers","year":"2017"},{"key":"10.1016\/j.jpba.2021.114147_bib0145","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1126\/science.aaf5171","article-title":"M.G. Vander Heiden, Tissue of origin dictates branched-chain amino acid metabolism in mutant Kras-driven cancers","volume":"353","author":"Mayers","year":"2016","journal-title":"Science."},{"key":"10.1016\/j.jpba.2021.114147_bib0150","first-page":"80","article-title":"Threonine metabolism and embryonic stem cell self-renewal","volume":"17","author":"Chen","year":"2014","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.jpba.2021.114147_bib0155","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/ijc.29564","article-title":"The pyruvate dehydrogenase complex in cancer: an old metabolic gatekeeper regulated by new pathways and pharmacological agents","volume":"138","author":"Saunier","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jpba.2021.114147_bib0160","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s11306-020-01694-y","article-title":"Plasma metabolomic profile in prostatic intraepithelial neoplasia and prostate cancer and associations with the prostate-specific antigen and the Gleason score","volume":"16","author":"Markin","year":"2020","journal-title":"Metabolomics"},{"key":"10.1016\/j.jpba.2021.114147_bib0165","doi-asserted-by":"crossref","DOI":"10.1111\/cas.14443","article-title":"Nuclear magnetic resonance-based tissue metabolomic analysis clarifies molecular mechanisms of gastric carcinogenesis","author":"Gu","year":"2020","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jpba.2021.114147_bib0170","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00726-020-02853-0","article-title":"Glycine metabolomic changes induced by anticancer agents in A549 cells","volume":"52","author":"Guo","year":"2020","journal-title":"Amino Acids"},{"key":"10.1016\/j.jpba.2021.114147_bib0175","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1158\/1541-7786.MCR-18-1068","article-title":"Urea cycle sustains cellular energetics upon EGFR inhibition in EGFR-Mutant NSCLC","volume":"17","author":"Pham-Danis","year":"2019","journal-title":"Mol. Cancer Res."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708521002582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708521002582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:13:11Z","timestamp":1760001191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708521002582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":35,"alternative-id":["S0731708521002582"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2021.114147","relation":{},"ISSN":["0731-7085"],"issn-type":[{"type":"print","value":"0731-7085"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liquid chromatography-mass spectrometry based metabolic characterization of pleural effusion in patients with acquired EGFR-TKI resistance","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2021.114147","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114147"}}